Orion Nutraceuticals Announces Results of Annual General and Special Meeting

Vancouver, British Columbia — July 7, 2025 — NewsWall — Orion Nutraceuticals Inc. (CSE: ORI) has announced the results of its Annual General and Special Meeting held on July 4, 2025, where all matters submitted to shareholders were approved. Sixteen shareholders, holding 4,823,184 common shares (16.46% of total), were represented at the meeting.

Shareholders approved setting the number of directors at three. Guy Bourgeois, Amanda Boudreau, and Troy Grant were elected as directors. Dale Matheson Carr-Hilton Labonte LLP was reappointed as auditor. Disinterested shareholder approval was obtained for the voluntary delisting of common shares from the Canadian Securities Exchange (CSE), although the board continues to review its position.

The resolution to transact other business was also approved. Orion Nutraceuticals Inc. is actively evaluating potential investment and acquisition opportunities.

Guy Bourgeois, Director, can be reached at (604) 687-2038.

Source: Orion Nutraceuticals